These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 28378454)

  • 1. GC-MS metabolomics-based approach for the identification of a potential VOC-biomarker panel in the urine of renal cell carcinoma patients.
    Monteiro M; Moreira N; Pinto J; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Carvalho M; Guedes de Pinho P
    J Cell Mol Med; 2017 Sep; 21(9):2092-2105. PubMed ID: 28378454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry.
    Rodrigues D; Pinto J; Araújo AM; Monteiro-Reis S; Jerónimo C; Henrique R; de Lourdes Bastos M; de Pinho PG; Carvalho M
    Metabolomics; 2018 Apr; 14(5):62. PubMed ID: 30830384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
    Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
    Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.
    Monteiro MS; Barros AS; Pinto J; Carvalho M; Pires-Luís AS; Henrique R; Jerónimo C; Bastos ML; Gil AM; Guedes de Pinho P
    Sci Rep; 2016 Nov; 6():37275. PubMed ID: 27857216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine metabolomics analysis for kidney cancer detection and biomarker discovery.
    Kim K; Aronov P; Zakharkin SO; Anderson D; Perroud B; Thompson IM; Weiss RH
    Mol Cell Proteomics; 2009 Mar; 8(3):558-70. PubMed ID: 19008263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of volatile human urinary metabolome by solid-phase microextraction in combination with gas chromatography-mass spectrometry for biomarker discovery: application in a pilot study to discriminate patients with renal cell carcinoma.
    Monteiro M; Carvalho M; Henrique R; Jerónimo C; Moreira N; de Lourdes Bastos M; de Pinho PG
    Eur J Cancer; 2014 Jul; 50(11):1993-2002. PubMed ID: 24820933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Volatile Organic Compounds as Potential Biomarkers in Idiopathic Membranous Nephropathy.
    Wang M; Xie R; Jia X; Liu R
    Med Princ Pract; 2017; 26(4):375-380. PubMed ID: 28633145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary metabolomics study of renal cell carcinoma based on gas chromatography-mass spectrometry].
    Zhang L; Li L; Kong H; Zeng F
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):763-6. PubMed ID: 26018279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
    Silva CL; Passos M; Câmara JS
    Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression.
    Wu HHL; Possell M; Nguyen LT; Peng W; Pollock CA; Saad S
    BMC Nephrol; 2024 Oct; 25(1):352. PubMed ID: 39407183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls.
    Cozzolino R; De Magistris L; Saggese P; Stocchero M; Martignetti A; Di Stasio M; Malorni A; Marotta R; Boscaino F; Malorni L
    Anal Bioanal Chem; 2014 Jul; 406(19):4649-62. PubMed ID: 24828982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UPLC-MS based urine untargeted metabolomic analyses to differentiate bladder cancer from renal cell carcinoma.
    Wang Z; Liu X; Liu X; Sun H; Guo Z; Zheng G; Zhang Y; Sun W
    BMC Cancer; 2019 Dec; 19(1):1195. PubMed ID: 31805976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs).
    Zhang S; Raftery D
    Methods Mol Biol; 2014; 1198():265-72. PubMed ID: 25270935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary Volatile Organic Compounds for the Detection of Prostate Cancer.
    Khalid T; Aggio R; White P; De Lacy Costello B; Persad R; Al-Kateb H; Jones P; Probert CS; Ratcliffe N
    PLoS One; 2015; 10(11):e0143283. PubMed ID: 26599280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The volatilome - investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC).
    Opitz P; Herbarth O
    J Otolaryngol Head Neck Surg; 2018 Jul; 47(1):42. PubMed ID: 29970175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer.
    Gao Q; Su X; Annabi MH; Schreiter BR; Prince T; Ackerman A; Morgas S; Mata V; Williams H; Lee WY
    Clin Genitourin Cancer; 2019 Jun; 17(3):183-190. PubMed ID: 30853355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine.
    Lima AR; Pinto J; Azevedo AI; Barros-Silva D; Jerónimo C; Henrique R; de Lourdes Bastos M; Guedes de Pinho P; Carvalho M
    Br J Cancer; 2019 Nov; 121(10):857-868. PubMed ID: 31588123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach.
    Amaro F; Pinto J; Rocha S; Araújo AM; Miranda-Gonçalves V; Jerónimo C; Henrique R; de Lourdes Bastos M; Carvalho M; de Pinho PG
    Metabolites; 2020 Apr; 10(5):. PubMed ID: 32349455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine volatile organic compounds as biomarkers for minimal change type nephrotic syndrome.
    Liu D; Zhao N; Wang M; Pi X; Feng Y; Wang Y; Tong H; Zhu L; Wang C; Li E
    Biochem Biophys Res Commun; 2018 Jan; 496(1):58-63. PubMed ID: 29291407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma.
    Pinto J; Amaro F; Lima AR; Carvalho-Maia C; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes de Pinho P
    J Proteome Res; 2021 Jun; 20(6):3068-3077. PubMed ID: 33797920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.